Inventor · disambiguated record
Nagesh K. Mahanthappa
Also filed as: MAHANTHAPPA NAGESH · MAHANTHAPPA NAGESH K
19 granted patents·16 pending applications·419 citations·filing 1994–2024
96Inventor score
Files withSCHOLAR ROCK INC19CURIS INC7CAMBRIDGE NEUROSCIENCE INC2GALDES ALPHONSE2ACORDA THERAPEUTICS1
Top patents by PatentIndex Score
35 records- 0197US9580500B2Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2015·Granted Feb 28, 2017·36 cites·8 claims
- 0297US9573995B2Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2015·Granted Feb 21, 2017·41 cites·10 claims
- 0397US9399676B2Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2015·Granted Jul 26, 2016·38 cites·7 claims
- 0495US10597443B2Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2017·Granted Mar 24, 2020·16 cites·23 claims
- 0594US11827698B2Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2021·Granted Nov 28, 2023·2 cites·23 claims
- 0694US10981981B2Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2018·Granted Apr 20, 2021·5 cites·24 claims
- 0794US9758576B2Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2015·Granted Sep 12, 2017·13 cites·10 claims
- 0894US9758577B2Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2016·Granted Sep 12, 2017·13 cites·16 claims
- 0992US11925683B2Compositions for making and using anti-Myostatin antibodiesSCHOLAR ROCK INC·Filed 2021·Granted Mar 12, 2024·2 cites·9 claims
- 1091US11135291B2Methods for making and using anti-myostatin antibodiesSCHOLAR ROCK INC·Filed 2019·Granted Oct 5, 2021·10 cites·26 claims
- 1191US10307480B2Anti-pro/latent-myostatin antibodies and uses thereofSCHOLAR ROCK INC·Filed 2015·Granted Jun 4, 2019·12 cites·19 claims
- 1291US5681568ADevice for delivery of substances and methods of use thereofCAMBRIDGE NEUROSCIENCE INC·Filed 1994·Granted Oct 28, 1997·120 cites·20 claims
- 1390US12454570B2Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2023·Granted Oct 28, 2025·0 cites·19 claims
- 1480US6750196B1Methods of treating disorders of the eyeACORDA THERAPEUTICS·Filed 1995·Granted Jun 15, 2004·47 cites·21 claims
- 1579US6087323AUse of neuregulins as modulators of cellular communicationCAMBRIDGE NEUROSCIENCE INC·Filed 1994·Granted Jul 11, 2000·42 cites·20 claims
- 1679US2024374718A1Anti-pro/latent-myostatin antibodies and uses thereofSCHOLAR ROCK INC·Filed 2024·Application pending·0 cites
- 1776US6884770B1Methods and compositions for treating or preventing peripheral neuropathiesCURIS INC·Filed 2000·Granted Apr 26, 2005·7 cites·15 claims
- 1867US2018022798A1Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2017·Application pending·0 cites
- 1966US2018016332A1Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2017·Application pending·0 cites
- 2064US2004235739A1Neuroprotective methods and reagentsCURIS INC·Filed 2004·Application pending·0 cites
- 2164US2017210798A1Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2017·Application pending·0 cites
- 2262US2008221037A1Methods and compositions for treating disorders involving excitotoxicityGALDES ALPHONSE·Filed 2008·Application pending·0 cites
- 2361US2010144616A1Neuroprotective methods and reagentsCURIS INC·Filed 2008·Application pending·0 cites
- 2454US6767888B1Neuroprotective methods and reagentsCURIS INC·Filed 1999·Granted Jul 27, 2004·8 cites·8 claims
- 2554US2020024339A1Compositions and methods for modulating cell signalingSCHOLAR ROCK INC·Filed 2019·Application pending·0 cites
- 2652US2015284455A1Compositions and methods for modulating cell signalingSCHOLAR ROCK INC·Filed 2013·Application pending·0 cites
- 2751US2007048286A1Method of treating dopaminergic and GABA-nergic disordersMIAO NINGNING·Filed 2006·Application pending·0 cites
- 2848US2007254364A1Methods and compositions for treating disorders involving excitotoxicityGALDES ALPHONSE·Filed 2007·Application pending·0 cites
- 2943US7138492B2Method of treating dopaminergic and GABA-nergic disordersCURIS INC·Filed 1999·Granted Nov 21, 2006·5 cites·8 claims
- 3040US2004220096A1Method and compositions for treating dopaminergic and gabanergic disordersCURIS INC·Filed 2003·Application pending·0 cites
- 3140US2017073406A1Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2015·Application pending·0 cites
- 3235US7144997B2Vertebrate embryonic patterning-inducing proteins, compositions and uses related thertoCURIS INC·Filed 1997·Granted Dec 5, 2006·2 cites·26 claims
- 3329US2003040465A1Neuregulins as modulators of cellular communicationFiled 1999·Application pending·0 cites
- 3428US2003083242A1Methods and compositions for treating or preventing peripheral neuropathiesFiled 1998·Application pending·0 cites
- 3527US2003162698A1Methods and compositions for treating dopaminergic and gaba-nergic disordersFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nagesh K. Mahanthappa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →